Precision medicine is an approach to patient care that allows doctors to select treatments that are most likely to help patients based on a genetic understanding of their disease. This may also be called personalized medicine.
PrecisionMed, Inc. offers vital products and services facilitating breakthroughs in genetics, drug discovery, biomarker research, and molecular diagnostics. They offer high quality, accurately annotated human biological material and are the largest private global source of longitudinally collected Human Cerebrospinal Fluid from living normal control as well as diseased populations.
Their focus on prospective longitudinal collections of blood products, cerebral spinal fluid and malignant tissue with associated relevant, detailed clinical data. All of their samples are collected in the United States under U.S. IRB approved clinical protocols. Collections span most therapeutic and diagnostic areas. Samples and data are procured through PrecisionMed, Inc. developed networks of research experienced specialist physician clinical sites.
Collections performed by PrecisionMed, Inc. have been part of U.S. NIH grants and have formed the basis of U.S. FDA submissions and subsequent U.S. FDA clearance for diagnostics. With our background and expertise in human sample procurement, PrecisionMed, Inc. is uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical and biotechnology companies. PrecisionMed, Inc. conducts sample procurement studies from collection concept to banked samples in record time. Our customers include nearly every major pharmaceutical and biotechnology company, as well as numerous academic and government research institutions.
Gov Archive – (source)
President Obama had launched the Precision Medicine Initiative — a bold new research effort to revolutionize how we improve health and treat disease. He said –
Until now, most medical treatments have been designed for the “average patient.” As a result of this “one-size-fits-all” approach, treatments can be very successful for some patients but not for others. Precision Medicine, on the other hand, is an innovative approach that takes into account individual differences in people’s genes, environments, and lifestyles. It gives medical professionals the resources they need to target the specific treatments of the illnesses we encounter, further develops our scientific and medical research, and keeps our families healthier.
Advances in Precision Medicine have already led to powerful new discoveries and several new treatments that are tailored to specific characteristics, such as a person’s genetic makeup, or the genetic profile of an individual’s tumor. This is helping transform the way we can treat diseases such as cancer: Patients with breast, lung, and colorectal cancers, as well as melanomas and leukemias, for instance, routinely undergo molecular testing as part of patient care, enabling physicians to select treatments that improve chances of survival and reduce exposure to adverse effects.
Precision Medicine Initiative?
To enable a new era of medicine through research, technology, and policies that empower patients, researchers, and providers to work together toward development of individualized care.
The future of precision medicine will enable health care providers to tailor treatment and prevention strategies to people’s unique characteristics, including their genome sequence, microbiome composition, health history, lifestyle, and diet. To get there, we need to incorporate many different types of data, from metabolomics (the chemicals in the body at a certain point in time), the microbiome (the collection of microorganisms in or on the body), and data about the patient collected by health care providers and the patients themselves. Success will require that health data is portable, that it can be easily shared between providers, researchers, and most importantly, patients and research participants.
Agencies across the Federal government are doing important work to support the President’s vision. This is an “all of government” effort, leveraging the unique expertise and history of each agency to carry forward the President’s vision of individualized treatments for every American.
Penn Medicine center for Precision Medicine –